Apolipoprotein J/clusterin limits the severity of murine autoimmune myocarditis. 2000

L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267-0575, USA.

Apolipoprotein J/clusterin (apoJ/clusterin), an intriguing protein with unknown function, is induced in myocarditis and numerous other inflammatory injuries. To test its ability to modify myosin-induced autoimmune myocarditis, we generated apoJ-deficient mice. ApoJ-deficient and wild-type mice exhibited similar initial onset of myocarditis, as evidenced by the induction of two early markers of the T cell-mediated immune response, MHC-II and TNF receptor p55. Furthermore, autoantibodies against the primary antigen cardiac myosin were induced to the same extent. Although the same proportion of challenged animals exhibited some degree of inflammatory infiltrate, inflammation was more severe in apoJ-deficient animals. Inflammatory lesions were more diffuse and extensive in apoJ-deficient mice, particularly in females. In marked contrast to wild-type animals, the development of a strong generalized secondary response against cardiac antigens in apoJ-deficient mice was predictive of severe myocarditis. Wild-type mice with a strong Ab response to secondary antigens appeared to be protected from severe inflammation. After resolution of inflammation, apoJ-deficient, but not wild-type, mice exhibited cardiac function impairment and severe myocardial scarring. These results suggest that apoJ limits progression of autoimmune myocarditis and protects the heart from postinflammatory tissue destruction.

UI MeSH Term Description Entries
D008297 Male Males
D009205 Myocarditis Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies. Carditis,Myocarditides
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D005260 Female Females
D006023 Glycoproteins Conjugated protein-carbohydrate compounds including MUCINS; mucoid, and AMYLOID glycoproteins. C-Glycosylated Proteins,Glycosylated Protein,Glycosylated Proteins,N-Glycosylated Proteins,O-Glycosylated Proteins,Glycoprotein,Neoglycoproteins,Protein, Glycosylated,Proteins, C-Glycosylated,Proteins, Glycosylated,Proteins, N-Glycosylated,Proteins, O-Glycosylated
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA

Related Publications

L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
October 2010, Circulation,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
June 1996, The American journal of pathology,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
August 2000, Microscopy research and technique,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
January 2023, Frontiers in aging neuroscience,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
November 2002, The international journal of biochemistry & cell biology,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
March 2002, Molecular and cellular biology,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
January 2014, PloS one,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
January 2011, In vivo (Athens, Greece),
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
December 1999, The Biochemical journal,
L McLaughlin, and G Zhu, and M Mistry, and C Ley-Ebert, and W D Stuart, and C J Florio, and P A Groen, and S A Witt, and T R Kimball, and D P Witte, and J A Harmony, and B J Aronow
January 1990, Immunology series,
Copied contents to your clipboard!